Clinical Trial

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Name: Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — clinical trial record (NCT07032662)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a Phase 2b study to evaluate the efficacy and safety of Imeroprubart in adults with CIDP.

Protocol Amendment History 2 changes

notable Trial sites expanded: 138 -> 141 locations 2026-07-31

notable Trial sites expanded: 135 -> 138 locations 2026-07-11

Trial Details

NCT Number	NCT07032662
Lead Sponsor	Immunovant Sciences GmbH
Conditions	Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment	162 participants
Start Date	2025-03-18
Primary Completion	2028-08 (estimated)
Study Completion	2030-05 (estimated)
Updated on ClinicalTrials.gov	2026-07-30